
Sinopharm to Inject $4.6 Bn Covid-19 Vaccine Assets Into Unit Tiantan Biological: Report
News 18Chinese state-owned Sinopharm plans to inject 30 billion yuan in assets into unit Beijing Tiantan Biological Products Corp Ltd to quickly get its fast-growing vaccine business on the public market, two people told Reuters. Sinopharm aims to begin the injection of six vaccine-focused biological products developers including makers of two COVID-19 vaccines into Shanghai-listed Tiantan in the coming weeks, said the people plus two other people with knowledge of the matter. The six units Sinopharm aims to inject into Tiantan develop and manufacture a range of vaccines including two for COVID-19 as well as injectable cosmetic Botox, their websites showed. One of the two COVID-19 vaccines, developed in Beijing, was the first approved for general public use in China in December, and has since gained emergency use approval in countries such as Iraq and Morocco.
History of this topic

Sino Biopharm targets 30 innovative products by 2027
China Daily
Mpox vaccine ready for clinical trial
China Daily
Mpox vaccine ready for clinical trial
China Daily
Large-scale COVID reemergence 'unlikely' despite uptick in cases
China Daily
Large-scale COVID reemergence 'unlikely' despite uptick in cases
China Daily
Large-scale COVID reemergence 'unlikely' despite uptick in cases
China Daily
China approves its first mRNA COVID-19 vaccine; here’s all you need to know
Live Mint
China approves its first mRNA vaccine for Covid-19
Hindustan Times
Vaccines from China bolster COVID fight
China Daily
No new Covid variants during recent breakout in China: Lancet study
India Today
COVID-19 update: China faces challenge due to flawed containment policies, ineffective vaccines, says Report
India TV News
Coronavirus in China: 'Funding issues won’t stand in the way of medical treatment,' says government
Firstpost
COVID-19 update: China reports nearly 60,000 coronavirus deaths since December 2022| DETAILS
India TV News
Chinese travellers head to Hong Kong for mRNA Covid vaccines: Report
Hindustan Times
COVID In 2023: Here's What Experts Expect
Huff Post
Six fallacies and truths about China's epidemic control
China Daily
No second Covid-19 booster dose required: Report
Live Mint
Amid COVID surge, China approves America’s Paxlovid, an anti-viral drug: Why this is an unlikely move
Firstpost
COVID-19: China races to vaccinate elderly amid rising cases, but many are reluctant
India TV News
China: Why older people are reluctant to get vaccinated despite rising COVID cases
Firstpost
China races to vaccinate the elderly, but many are reluctant
LA Times
China sees nearly 37 million new Covid cases in one single day, says report
India TV News
Despite soaring cases, Chinese reluctant to take COVID vaccine amid fears of its potential side effects
India TV News
Nearly 250 million Covid-19 infections in China in just 20 days: Leaked doc
Live Mint
After Slow Start, Demand for Covid-19 Booster Shots Spikes as China's New Wave Triggers Panic in India
News 18
Explained: Are Chinese vaccines to blame for its COVID-19 surge?
Firstpost
One-day tally of COVID cases in China hits 37 million: Report
Al Jazeera
Prepare, don't panic, in the face of covid resurgence in China
Live Mint
Big bonuses, extreme rationing: How Covid-hit China is coping with its drugs shortage
CNN
A concerning sequence: The Hindu Editorial on a new coronavirus strain and a spurt in cases in China
The Hindu
China says no new Covid deaths, but crematoriums ‘overwhelmed’ | Top points
Hindustan Times
BioNTech-Pfizer COVID vaccine sent to China for Germans
Associated Press
Rising COVID cases news from China is concerning: SII CEO Adar Poonawala, urges people not to panic
Firstpost
China's recent coronavirus outbreak is a scathing indictment of its homemade vaccines
Op India
'Rising Covid cases in China concerning,' says Serum Institute's Adar Poonawalla
Hindustan Times
What is China's latest Covid situation? 5 points
Hindustan Times
WHO chief ‘very concerned’ over COVID situation in China
Al Jazeera
US concerned about ‘new mutations’ of virus from China's Covid outbreak
Hindustan Times
Scary predictions on how many could die from Covid in China
Live Mint
China’s COVID-19 outbreak has U.S. worried about new variants
LA Times
New COVID model predicts over 1 million deaths in China through 2023
The Hindu
Inhalable COVID-19 vaccinations available in Shandong
China Daily
A week into easing, uncertainty over China virus direction
The Independent
China won’t report asymptomatic COVID cases in further shift
Associated Press
In another big change, China says it won't report asymptomatic COVID cases
Firstpost
Why vaccine hesitancy persists in China — and what they're doing about it
NPR
China’s Beijing eases COVID curbs after rare protests
Al Jazeera
China: Embracing a planned exit from zero-COVID strategy
The Hindu
WHO Pleased to See China Ease Harsh Zero Covid Policies
News 18
WHO pleased to see China ease harsh zero COVID policies
The IndependentDiscover Related










































